Table 1 Clinicopathologic parameters and AGR2 expression in patients with prostate cancer
From: Differential expression of anterior gradient gene AGR2 in prostate cancer
| Â | All patients | Mean AGR2 expression (SE) | P-value |
|---|---|---|---|
Total cases | 187 | 0.548 (0.040) | Â |
Age at surgery | Â | Â | 0.9292 |
   Median (range) | 65 (46-76) |  |  |
   Mean | 63.7 |  |  |
Gleason score | Â | Â | 0.9861 |
   2-6 | 107 | 0.544 (0.052) |  |
   7-10 | 80 | 0.553 (0.064) |  |
Stage | Â | Â | Â |
   I/II | 122 | 0.559 (0.054) | 0.7641 |
   III/IV | 65 | 0.527 (0.057) |  |
pT stage | Â | Â | 0.7671 |
   pT2-pT3a | 152 | 0.560 (0.047) |  |
   pT3b | 35 | 0.495 (0.076) |  |
Lymph node status | Â | Â | 0.1801 |
   Positive | 11 | 0.353 (0.118) |  |
   Negative | 174 | 0.564 (0.043) |  |
Tumor margins | Â | Â | 0.3471 |
   Positive | 64 | 0.490 (0.060) |  |
   Negative | 123 | 0.578 (0.053) |  |
Capsular invasion | Â | Â | 0.4841 |
   No invasion | 43 | 0.573 (0.107) |  |
   Invasion | 144 | 0.540 (0.042) |  |
Organ confined | Â | Â | 0.4771 |
   Yes | 93 | 0.598 (0.066) |  |
   No | 94 | 0.498 (0.047) |  |
PSA ng/mL | Â | Â | 0.3392 |
   Median (range) | 9.6 (0.6-96.5) |  | 0.4131 |
   Mean | 14.0 |  |  |
   < 10 | 88 | 0.509 (0.057) |  |
   ≥10 | 79 | 0.563 (0.064) |  |